Top Headlines: 13 Indian firms to make Covid pill; bank NPAs at 6-year low

Business Standard brings you the top headlines at this hour.

13 Indian firms set to boost India's anti-Covid arsenal with a pill

Thirteen Indian companies can now manufacture and market oral antiviral drug Molnupiravir developed by Merck and Ridgeback Biotherapeutics after the country’s drug regulator granted approval for restricted use under emergency situations for Covid-infected adults in high-risk category. Read more
 

Bank NPAs ease to nearly six-year low: RBI Trends & Progress report

Proving sceptics wrong, 2020-21 turned out to be the best in recent years for Indian banks in terms of their financial performance. The pandemic-hit financial year was marked by a “discernible increase” in profitability, as banks’